Aberrant ALK and IGF-1R signaling have been demonstrated to contribute to oncogenic transformation in pediatric sarcomas [39] and the involvement of IGF-1R signaling in resistance to HDACi was reported in NSCLC [40]. Here, IGF1R is linked to non-small cell lung carcinoma.